Warfarin vs. Pradaxa
See how Warfarin and Pradaxa compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Warfarin requires regular INR blood tests and a steady vitamin K intake, while Pradaxa is taken at a fixed dose without routine coagulation monitoring.
Brand-name Pradaxa costs far more out of pocket than warfarin, which is one of the least expensive oral anticoagulants available.
Both drugs increase bleeding risk, but warfarin's effects can be reversed with vitamin K while Pradaxa has its own dedicated reversal agent for emergencies.
Warfarin vs. Pradaxa Drug Summary
Warfarin
Warfarin is a vitamin K antagonist that prevents and treats blood clots, including deep vein thrombosis, pulmonary embolism, and clot-related strokes from atrial fibrillation or heart valve replacement. It is taken as a once-daily tablet, with the dose adjusted based on regular INR blood tests.
Pradaxa
Pradaxa (dabigatran) is a direct thrombin inhibitor that lowers stroke risk in people with nonvalvular atrial fibrillation and treats or prevents blood clots such as DVT and PE. It is taken as a fixed-dose capsule, usually twice daily, without routine blood test monitoring.
Warfarin vs. Pradaxa Side Effects
Warfarin
Pradaxa
Warfarin vs. Pradaxa Dosage
Warfarin
Pradaxa
| STAGE | DOSE | WHEN |
| Starting dose | 2 mg to 5 mg once daily | Days 1-4 |
| Maximum dose | 2 mg to 10 mg once daily | Day 5 onward |
| Dose changes | 1 increase | Every 4 days |
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg twice daily | At the start |
| Maximum dose | 220 mg once daily | Days 2-35 |
| Dose changes | 3 increases | Every day |
Warfarin
| STAGE | DOSE | WHEN |
| Starting dose | 2 mg to 5 mg once daily | Days 1-4 |
| Maximum dose | 2 mg to 10 mg once daily | Day 5 onward |
| Dose changes | 1 increase | Every 4 days |
Pradaxa
| STAGE | DOSE | WHEN |
| Starting dose | 150 mg twice daily | At the start |
| Maximum dose | 220 mg once daily | Days 2-35 |
| Dose changes | 3 increases | Every day |
Warfarin vs. Pradaxa Indications
Warfarin
Warfarin prevents and treats blood clots in the veins and lungs, and lowers the risk of stroke from atrial fibrillation or mechanical heart valves. It is also used after a heart attack to reduce the risk of death, another heart attack, or stroke.
Treats and prevents deep vein thrombosis and pulmonary embolism
Prevents stroke and clots from atrial fibrillation
Prevents clots after mechanical heart valve replacement
Reduces risk of death and recurrent event after a heart attack
Pradaxa
Pradaxa lowers the risk of stroke and blood clots in people with nonvalvular atrial fibrillation. It also treats deep vein thrombosis and pulmonary embolism, helps prevent their recurrence, and prevents clots after hip replacement surgery.
Lowers stroke and systemic embolism risk in nonvalvular AFib
Treats deep vein thrombosis and pulmonary embolism
Reduces risk of DVT or PE recurrence after initial treatment
Prevents blood clots after hip replacement surgery
Warfarin vs. Pradaxa Pros and Cons
Warfarin
Warfarin has decades of real-world use and is one of the least expensive oral anticoagulants, but it demands regular blood testing and careful attention to diet and drug interactions. Coverage is nearly universal since it has been a generic staple for decades.
Pros
Typically $4 to $35 per month without insurance
Long track record of use since 1954, well understood by prescribers
Bleeding effects can be reversed with vitamin K
Only oral anticoagulant approved for mechanical heart valve patients
Cons
Requires regular INR blood tests and dose adjustments
Effectiveness is affected by diet, alcohol, and many medications
Narrow therapeutic window raises risk of under- or over-anticoagulation
Pradaxa
Pradaxa offers fixed dosing without routine blood test monitoring, but brand-name pricing runs much higher than warfarin's generic tablets. It is generally covered by insurance, though generic dabigatran can bring the cost down.
Pros
Fixed dosing without need for routine blood monitoring
Fewer food and drug interactions than warfarin
Specific reversal agent (idarucizumab) available for emergencies
Lower risk of intracranial bleeding than warfarin in clinical trials
Cons
Brand-name cost roughly $400 to $530 per month, before savings programs
Higher rate of GI side effects like dyspepsia and stomach upset
Requires dose adjustment or avoidance with significant kidney impairment
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.